Dedeciusova Michaela, Svoboda Norbert, Benes Vladimir, Astl Jaromir, Netuka David
Department of Neurosurgery and Neurooncology, First Faculty of Medicine, Charles University and Military University Hospital, Prague, Czech Republic.
Department of Otorhinolaryngology and Maxillofacial Surgery, Third Faculty of Medicine, Charles University and Military University Hospital, Prague, Czech Republic.
J Neurol Surg A Cent Eur Neurosurg. 2020 Jul;81(4):310-317. doi: 10.1055/s-0040-1709165. Epub 2020 May 3.
Clinical examination, including pre- and postoperative assessment of olfaction, is essential in evaluating surgical outcomes in patients with olfactory groove meningiomas (OGMs). A review of a recent series revealed a lack of assessment of olfaction in most of the studies. Tests determining olfactory detection should be used to reveal olfactory dysfunction. Specialized examination techniques (e.g., electro-olfactography, olfactory evoked potentials, and functional magnetic resonance imaging) are currently used in research.
Prospective analysis of 13 patients who underwent surgical resection of OGMs from December 2013 to December 2017 was performed. Data on clinical presentation, pre- and postoperative neurologic examinations, complications, recurrences, adjuvant treatment, and follow-up outpatient examinations were recorded. Olfactory function was assessed using the Sniffin' Sticks odor identification test preoperatively, postoperatively, and 1 year after surgery.
All the meningiomas were resected via unilateral craniotomy, and gross total resection was achieved in all cases. Surgery-related permanent morbidity was 7.7% and overall mortality 0%. For the eight patients with preoperative normosmia, five remained normosmic (62.5%), one deteriorated to hyposmia (12.5%), and two deteriorated to anosmia (25%). For the two patients with preoperative hyposmia, one remained hyposmic and one deteriorated to anosmia. For the three anosmic patients, two remained anosmic, and one improved to hyposmia.The intact olfactory function preoperatively was associated with a better olfactory outcome. Overall, 62.5% of these patients remained normosmic, and none of the hyposmic or anosmic patients normalized their olfaction.Higher meningioma volume is associated with worse olfactory function before surgery (normosmia in 16.7% versus 100.0% in less voluminous) and following the surgery (normosmia in 16.7% versus 57.1% less voluminous).The unilateral surgical approach enabled the anatomical preservation of the contralateral olfactory nerve in 76.9% of our patients. Functional normosmia was achieved in 50% and hyposmia in 30% of these cases.
Assessment of olfactory function is both vital in preoperative decision making (surgical approach, radicality of resection) and when evaluating surgical outcome. Preoperative normosmia seems to be the most important prognostic factor for functional olfactory outcome. In normosmic patients the olfaction was preserved in 62.5% of cases. Moreover, higher meningioma volume is associated with worse olfactory function before and following the surgery. The greatest advantage of the unilateral surgical approach is anatomical preservation of the contralateral olfactory nerve with a satisfactory functional outcome. These results support a proactive approach, with early surgical resection using a unilateral approach even in cases with less voluminous OGMs that enables the preservation of olfactory function in a significant proportion of patients.
临床检查,包括术前和术后嗅觉评估,对于评估嗅沟脑膜瘤(OGM)患者的手术效果至关重要。对近期一系列研究的回顾显示,大多数研究缺乏对嗅觉的评估。应使用确定嗅觉检测的测试来揭示嗅觉功能障碍。目前研究中使用了专门的检查技术(如电子嗅觉图、嗅觉诱发电位和功能磁共振成像)。
对2013年12月至2017年12月接受OGM手术切除的13例患者进行前瞻性分析。记录临床表现、术前和术后神经系统检查、并发症、复发、辅助治疗以及随访门诊检查的数据。术前、术后及术后1年使用嗅棒气味识别测试评估嗅觉功能。
所有脑膜瘤均通过单侧开颅手术切除,所有病例均实现了全切。手术相关的永久性发病率为7.7%,总死亡率为0%。对于8例术前嗅觉正常的患者,5例仍保持嗅觉正常(62.5%),1例恶化为嗅觉减退(12.5%),2例恶化为嗅觉丧失(25%)。对于2例术前嗅觉减退的患者,1例仍为嗅觉减退,1例恶化为嗅觉丧失。对于3例嗅觉丧失的患者,2例仍为嗅觉丧失,1例改善为嗅觉减退。术前嗅觉功能完好与更好的嗅觉结果相关。总体而言,这些患者中有62.5%保持嗅觉正常,嗅觉减退或丧失的患者中无一例嗅觉恢复正常。更大的脑膜瘤体积与术前(16.7%嗅觉正常,体积较小者为100.0%)和术后(16.7%嗅觉正常,体积较小者为57.1%)更差的嗅觉功能相关。单侧手术入路使76.9%的患者对侧嗅神经得以解剖保留。这些病例中50%实现了功能性嗅觉正常,30%为嗅觉减退。
嗅觉功能评估在术前决策(手术入路、切除程度)和评估手术效果时都至关重要。术前嗅觉正常似乎是功能性嗅觉结果最重要的预后因素。在嗅觉正常的患者中,62.5%的病例嗅觉得以保留。此外,更大的脑膜瘤体积与手术前后更差的嗅觉功能相关。单侧手术入路的最大优势是对侧嗅神经的解剖保留以及令人满意的功能结果。这些结果支持一种积极的方法,即即使在OGM体积较小的病例中,也采用单侧入路进行早期手术切除,这能在相当比例的患者中保留嗅觉功能。